Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
22QA1405700
Funder:
Shanghai Rising-Star Program
Topic:
Parkinson's Disease Mechanisms and Treatments
Subfield:
Clinical Neurology
Field:
Medicine
Domain:
Health Sciences
Funded outputs count:
7
Funder award ID:
22QA1405700
OpenAlex ID:
G770611793
Gut ecosystem dysfunction in parkinson’s disease: deciphering faecal metabolome-metagenome links for novel diagnostic panels
2026
·
Yiwei Qian
, Shaoqing Xu
, et al.
·
npj Parkinson s Disease
·
2
PDF
Neuroprotective effects of Bifidobacterium animalis HN019 and Lactobacillus acidophilus NCFM in MPTP-induced Parkinson’s disease mice
2026
·
Chengjun Mo
, Yiwei Qian
, et al.
·
Brain Behavior and Immunity
·
4
Gut microbial community of patients with Parkinson’s disease analyzed using metagenome-assembled genomes
2025
·
Yi Zhang
, Chengjun Mo
, et al.
·
Neural Regeneration Research
·
5
Targeted Gut Microbiota Modulation Enhances Levodopa Bioavailability and Motor Recovery in MPTP Parkinson’s Disease Models
2025
·
Penghui Ai
, Shaoqing Xu
, et al.
·
International Journal of Molecular Sciences
·
17
PDF
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
2025
·
Yi Zhang
, Chengjun Mo
, et al.
·
Gut Microbes
·
20
Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson’s disease
2025
·
Xiaoqin He
, Kai Shi
, et al.
·
Clinical Parkinsonism & Related Disorders
·
2
Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease
2024
·
Xiaoqin He
, Yiqiu Lai
, et al.
·
Microorganisms
·
7
Show more works
View as search